ATP1A2
Sodium/potassium-transporting ATPase subunit alpha-2
Also known as: AT1A2_HUMAN, FHM2, MHP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P50993
- Gene
- ATP1A2
- Ensembl
- ENSG00000018625
- Chromosome
- 1
- Canonical length
- 1020 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 2 subunit. Mutations in this gene result in familial basilar or hemiplegic migraines, and in a rare syndrome known as alternating hemiplegia of childhood. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
1020 residues, UniProt reviewed canonical sequence.
>P50993|ATP1A2
1 MGRGAGREYS PAATTAENGG GKKKQKEKEL DELKKEVAMD DHKLSLDELG RKYQVDLSKG
61 LTNQRAQDVL ARDGPNALTP PPTTPEWVKF CRQLFGGFSI LLWIGAILCF LAYGIQAAME
121 DEPSNDNLYL GVVLAAVVIV TGCFSYYQEA KSSKIMDSFK NMVPQQALVI REGEKMQINA
181 EEVVVGDLVE VKGGDRVPAD LRIISSHGCK VDNSSLTGES EPQTRSPEFT HENPLETRNI
241 CFFSTNCVEG TARGIVIATG DRTVMGRIAT LASGLEVGRT PIAMEIEHFI QLITGVAVFL
301 GVSFFVLSLI LGYSWLEAVI FLIGIIVANV PEGLLATVTV CLTLTAKRMA RKNCLVKNLE
361 AVETLGSTST ICSDKTGTLT QNRMTVAHMW FDNQIHEADT TEDQSGATFD KRSPTWTALS
421 RIAGLCNRAV FKAGQENISV SKRDTAGDAS ESALLKCIEL SCGSVRKMRD RNPKVAEIPF
481 NSTNKYQLSI HEREDSPQSH VLVMKGAPER ILDRCSTILV QGKEIPLDKE MQDAFQNAYM
541 ELGGLGERVL GFCQLNLPSG KFPRGFKFDT DELNFPTEKL CFVGLMSMID PPRAAVPDAV
601 GKCRSAGIKV IMVTGDHPIT AKAIAKGVGI ISEGNETVED IAARLNIPMS QVNPREAKAC
661 VVHGSDLKDM TSEQLDEILK NHTEIVFART SPQQKLIIVE GCQRQGAIVA VTGDGVNDSP
721 ALKKADIGIA MGISGSDVSK QAADMILLDD NFASIVTGVE EGRLIFDNLK KSIAYTLTSN
781 IPEITPFLLF IIANIPLPLG TVTILCIDLG TDMVPAISLA YEAAESDIMK RQPRNSQTDK
841 LVNERLISMA YGQIGMIQAL GGFFTYFVIL AENGFLPSRL LGIRLDWDDR TMNDLEDSYG
901 QEWTYEQRKV VEFTCHTAFF ASIVVVQWAD LIICKTRRNS VFQQGMKNKI LIFGLLEETA
961 LAAFLSYCPG MGVALRMYPL KVTWWFCAFP YSLLIFIYDE VRKLILRRYP GGWVEKETYYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP1A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 826 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 826 nTPM
- basal ganglia: 583 nTPM
- tongue: 447 nTPM
- cerebral cortex: 441 nTPM
- amygdala: 435 nTPM
- midbrain: 329 nTPM
Single-cell type
- myonuclei: 1,205 nCPM
- bergmann glia: 896 nCPM
- astrocytes: 818 nCPM
- thymic myoid cells: 702 nCPM
- pituicytes/fscs: 463 nCPM
- adipocytes: 330 nCPM
Immune cell
- basophil: 0.2 nTPM
- neutrophil: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- thalamus: 835 nTPM
- midbrain: 736 nTPM
- basal ganglia: 735 nTPM
- medulla oblongata: 634 nTPM
- cerebellum: 614 nTPM
- amygdala: 578 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP1A2.
Disease | AllUniProt
Conditions ATP1A2 is implicated in, by any mechanism.
- Migraine, familial hemiplegic, 2 (FHM2) MIM:602481
- Alternating hemiplegia of childhood 1 (AHC1) MIM:104290
- Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies (FARIMPD) MIM:619602
- Developmental and epileptic encephalopathy 98 (DEE98) MIM:619605
Disease | GeneticClinVar
136 pathogenic / likely-pathogenic of 1,558 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Familial hemiplegic migraine
- Migraine, familial hemiplegic, 2
- Developmental and epileptic encephalopathy 98
- Alternating hemiplegia of childhood 1
- Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.5
- gnomAD pLI
- 0
- gnomAD missense Z
- 4.77
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult locomotory behavior
- amygdala development
- ATP metabolic process
- behavioral fear response
- cardiac muscle contraction
- cell communication by electrical coupling involved in cardiac conduction
- cellular response to mechanical stimulus
- cellular response to steroid hormone stimulus
- intracellular potassium ion homeostasis
- intracellular sodium ion homeostasis
- L-ascorbic acid metabolic process
- locomotion
- locomotory exploration behavior
- membrane depolarization during cardiac muscle cell action potential
- membrane repolarization
- monoatomic cation transmembrane transport
- negative regulation of calcium ion transmembrane transport
- negative regulation of cytosolic calcium ion concentration
- negative regulation of heart contraction
- negative regulation of striated muscle contraction
- neuronal action potential propagation
- neurotransmitter uptake
- positive regulation of heart contraction
- potassium ion import across plasma membrane
- potassium ion transmembrane transport
- potassium ion transport
- proton transmembrane transport
- regulation of blood pressure
- regulation of cardiac muscle cell contraction
- regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
- regulation of glutamate uptake involved in transmission of nerve impulse
- regulation of muscle contraction
- regulation of respiratory gaseous exchange by nervous system process
- regulation of smooth muscle contraction
- regulation of striated muscle contraction
- regulation of synaptic transmission, glutamatergic
- regulation of the force of heart contraction
- regulation of vasoconstriction
- relaxation of cardiac muscle
- response to auditory stimulus
- response to glycoside
- response to nicotine
- response to potassium ion
- sodium ion export across plasma membrane
- sodium ion transmembrane transport
- sodium ion transport
- transport across blood-brain barrier
- visual learning
- olfactory cortex development
Molecular functions
- ATP binding
- ATP hydrolysis activity
- ATPase-coupled monoatomic cation transmembrane transporter activity
- P-type sodium:potassium-exchanging transporter activity
- phosphatase activity
- potassium ion binding
- protein heterodimerization activity
- protein-folding chaperone binding
- sodium ion binding
- steroid binding
- steroid hormone binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- Cation-transporting P-type ATPase, N-terminal
- P-type ATPase subfamily IIC, subunit alpha
- Cation-transporting P-type ATPase, C-terminal
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- Cation transport ATPase (P-type)
- P-type ATPase, A domain
- P-type ATPase actuator domain
- Cation transporting ATPase, C-terminus
- Cation transporter/ATPase, N-terminus
- P-type ATPase, cytoplasmic domain N
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP1A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP1A2 as an antibody target. Whether an autoantibody or antibody against ATP1A2 could matter depends on whether native ATP1A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP1A2 is annotated at the cell surface, where native ATP1A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP1A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...